Filtered By:
Infectious Disease: COVID-19
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 5132 results found since Jan 2013.
Methods to Engage Patients in the Modern Clinic
CONCLUSION: These technological advances provide distinct advantages to the provider and patient, but also have a burden of time for evaluation of the data for the provider and disparate access to certain technologies for patients. The development of these technologies has been fast-tracked since the start of the Covid-19 pandemic. With the explosion in telehealth and medical device development, advancement of medical technology is not showing any signs of slowing down. It is paving a new way to interact with patients in the future.PMID:34813954 | DOI:10.1016/j.anai.2021.11.013
Source: Annals of Allergy, Asthma and Immunology - November 23, 2021 Category: Allergy & Immunology Authors: Laura E Maurer Chandani Bansal Priya Bansal Source Type: research
The adverse reactions to vaccines practice parameter 10 years on -what have we learned?
CONCLUSION: The risk of reactions to vaccination should be weighed against the risk of suffering a vaccine-preventable disease if the vaccine is withheld. There is no need to ask about egg allergy prior to the administration of influenza vaccines, including on screening forms. In most cases, an allergy to a vaccine constituent is not a contraindication to the vaccine containing it. Patients who have had possible anaphylactic reactions to vaccines should be evaluated by an allergist rather than simply being labeled allergic, because most can go on to receive subsequent doses. Most immediate reactions to COVID-19 vaccines ar...
Source: Annals of Allergy, Asthma and Immunology - February 1, 2022 Category: Allergy & Immunology Authors: John M Kelso Source Type: research
Allergic Reactions to the COVID-19 vaccine (ARCOV) study: the McGill University Health Center (MUHC) experience
CONCLUSION: In this cohort of patients with a history of anaphylaxis and increased risk of allergic reactions to the COVID-19 vaccines, following allergist evaluation, including negative PEG skin testing, the vaccine was safely administered without any serious adverse events.PMID:35609744 | PMC:PMC9124043 | DOI:10.1016/j.anai.2022.05.014
Source: Annals of Allergy, Asthma and Immunology - May 24, 2022 Category: Allergy & Immunology Authors: Faisal ALMuhizi Michael Fein Sofianne Gabrielli Louise Gilbert Christos Tsoukas Moshe Ben-Shoshan Ana M Copaescu Ghislaine A C Isabwe Source Type: research
Assessment and management of allergy history with a novel mRNA vaccine
Ann Fam Med. 2022 Apr 1;20(20 Suppl 1). doi: 10.1370/afm.20.s1.3135.ABSTRACTCONTEXT: Tertiary care hospital provided onsite COVID-19 vaccine roll out as a work benefit for all care team members with medically supervised waiting period at the time of the distribution of the first round of the novel mRNA COVID-19 vaccines. Little was known about the immediate hypersensivity reactions or what might predispose to cross reactivity.OBJECTIVE: We developed a working protocol to continuously track the vaccines administered, the patient history of allergy and hypersensistivity, the reactions observed and the care plan developed (de...
Source: Annals of Family Medicine - July 26, 2022 Category: Primary Care Authors: Christina Holt Jesse Butler Katie Sharp John McDonald Source Type: research
Iodine allergy: Common misperceptions.
CONCLUSION: There is a lack of evidence to support cross-reactivity between iodine-containing compounds in so called iodine-allergic individuals.
PMID: 33547463 [PubMed - as supplied by publisher]
Source: American Journal of Health-System Pharmacy : AJHP - February 6, 2021 Category: Drugs & Pharmacology Authors: Wulf NR, Schmitz J, Choi A Tags: Am J Health Syst Pharm Source Type: research
Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation
Clin Immunol. 2021 Apr 28:108748. doi: 10.1016/j.clim.2021.108748. Online ahead of print.ABSTRACTReports about cases of anaphylaxis to mRNA vaccines have created anxiety in the community and could increase vaccine hesitancy in the population. There are no standardized protocols for allergy testing to mRNA vaccines. PEG is currently the only excipient in both vaccines with recognized allergenic potential. Allergy to PEG has been reported with increasing frequency over recent years, often in patients who had repeated systemic allergic reactions/anaphylaxis to several classes of drugs before diagnosis. Proposed protocols are ...
Source: Clinical Immunology - May 1, 2021 Category: Allergy & Immunology Authors: Viktorija Erdeljic Turk Source Type: research
